| Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus M Stahl, M Stuschke, N Lehmann, HJ Meyer, MK Walz, S Seeber, ... Journal of clinical oncology 23 (10), 2310-2317, 2005 | 1575 | 2005 |
| Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction M Stahl, MK Walz, M Stuschke, N Lehmann, HJ Meyer, ... Journal of clinical oncology 27 (6), 851-856, 2009 | 1221 | 2009 |
| Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines V Grégoire, K Ang, W Budach, C Grau, M Hamoir, JA Langendijk, A Lee, ... Radiotherapy and Oncology 110 (1), 172-181, 2014 | 811 | 2014 |
| CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines CL Brouwer, RJHM Steenbakkers, J Bourhis, W Budach, C Grau, ... Radiotherapy and Oncology 117 (1), 83-90, 2015 | 602 | 2015 |
| A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of … W Budach, T Hehr, V Budach, C Belka, K Dietz BMC cancer 6, 1-12, 2006 | 420 | 2006 |
| Radiation induced CNS toxicity–molecular and cellular mechanisms C Belka, W Budach, RD Kortmann, M Bamberg British journal of cancer 85 (9), 1233-1239, 2001 | 389 | 2001 |
| Phase III study of surgery versus definitive concurrent chemoradiotherapy boost in patients with resectable stage IIIA (N2) and selected IIIB non–small-cell lung cancer after … WEE Eberhardt, C Pöttgen, TC Gauler, G Friedel, S Veit, V Heinrich, ... Journal of Clinical Oncology 33 (35), 4194-4201, 2015 | 374 | 2015 |
| Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone … V Budach, M Stuschke, W Budach, M Baumann, D Geismar, ... Journal of clinical oncology 23 (6), 1125-1135, 2005 | 373 | 2005 |
| Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis B Lacas, J Bourhis, J Overgaard, Q Zhang, V Grégoire, M Nankivell, ... The Lancet Oncology 18 (9), 1221-1237, 2017 | 348 | 2017 |
| Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression S Gripp, S Moeller, E Bölke, G Schmitt, C Matuschek, S Asgari, ... Journal of Clinical Oncology 25 (22), 3313-3320, 2007 | 319 | 2007 |
| German S3-guideline" Diagnosis and treatment of esophagogastric cancer" M Moehler, SE Al-Batran, T Andus, M Anthuber, J Arends, D Arnold, ... Zeitschrift fur Gastroenterologie 49 (4), 461-531, 2011 | 306 | 2011 |
| Face masks: benefits and risks during the COVID-19 crisis C Matuschek, F Moll, H Fangerau, JC Fischer, K Zänker, M van Griensven, ... European journal of medical research 25, 1-8, 2020 | 286 | 2020 |
| Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial M Stahl, MK Walz, J Riera-Knorrenschild, M Stuschke, A Sandermann, ... European Journal of Cancer 81, 183-190, 2017 | 267 | 2017 |
| Heart toxicity from breast cancer radiotherapy: current findings, assessment, and prevention MD Piroth, R Baumann, W Budach, J Dunst, P Feyer, R Fietkau, W Haase, ... Strahlentherapie und Onkologie 195 (1), 1, 2019 | 209 | 2019 |
| Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update J Biau, M Lapeyre, I Troussier, W Budach, J Giralt, C Grau, J Kazmierska, ... Radiotherapy and Oncology 134, 1-9, 2019 | 189 | 2019 |
| High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes C Giro, B Berger, E Bölke, IF Ciernik, F Duprez, L Locati, S Maillard, ... Radiotherapy and Oncology 90 (2), 166-171, 2009 | 178 | 2009 |
| Apoptosis-modulating agents in combination with radiotherapy—current status and outlook C Belka, V Jendrossek, M Pruschy, S Vink, M Verheij, W Budach International Journal of Radiation Oncology* Biology* Physics 58 (2), 542-554, 2004 | 178 | 2004 |
| Differential role of caspase-8 and BID activation during radiation-and CD95-induced apoptosis C Belka, J Rudner, S Wesselborg, A Stepczynska, P Marini, ... Oncogene 19 (9), 1181-1190, 2000 | 178 | 2000 |
| DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer F Sedlmayer, ML Sautter-Bihl, W Budach, J Dunst, G Fastner, P Feyer, ... Strahlentherapie Und Onkologie 189 (10), 825, 2013 | 177 | 2013 |
| Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up M Stahl, W Budach, HJ Meyer, A Cervantes Annals of oncology 21, v46-v49, 2010 | 174 | 2010 |
